VRTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VRTX shares is 2159, representing 95.82% of the company's common stock.

DEUTSCHE BANK AG\, in the last quarter, reduced its stake in VRTX by -4.24% restricting it's holding to 1.58 million shares of worth nearly $659.14M. CHEVY CHASE TRUST HOLDINGS, LLC also lessened -0.25% of the VRTX shares from its portfolio, reducing its holding to 443.83 thousand shares of worth $185.52M. ZURCHER KANTONALBANK (ZURICH CANTONALBANK) also shunned VRTX shares holding by -2.44% last quarter which brought its holding to 434.33 thousand shares worth $181.56M.

As per its latest 13F filing, NATIONAL PENSION SERVICE increased its stake in VRTX by 0.87% in the last quarter. The institutional holder raised its holding to 454.54 thousand shares having worth more than $190.00M. ROYAL LONDON ASSET MANAGEMENT LTD also added 7.33% more shares of VRTX to its portfolio, raising its holding to 416.25 thousand shares of worth $173.99M. NEUBERGER BERMAN GROUP LLC also increased its VRTX shares holding by 4.62% which brought its holding to 414.05 thousand shares worth $173.08M.

The insider with the most stakes in VRTX is Kewalramani Reshma , CEO & President at the company. Additionally, VRTX stock is highly held by EVP Chief Patient & Ext Af Off Sachdev Amit and EVP, COO Arbuckle Stuart A among others.

Company executives, directors, and other insiders own 0.08% percent of Vertex Pharmaceuticals Incorporated's stock. Within the last six months, there have been 6 transaction(s) in which VRTX insiders have sold stock, totaling 23.64K shares. Insiders that have sold shares include ALTSHULER DAVID, WAGNER CHARLES F JR, and KEWALRAMANI RESHMA.

There have been 0 transaction(s) during the past 6-months in which Vertex Pharmaceuticals Incorporated insiders have bought stock, totalling 0 shares

Around 176.8K Vertex Pharmaceuticals Incorporated shares are held by insiders, which represents about 0.08% of VRTX stock.

VRTX CEO & President, Kewalramani Reshma holds the largest portfolio of the company's shares. VRTX shares owned by Kewalramani total nearly 75.77 thousand.

DEUTSCHE BANK AG\ is the largest institutional owner in VRTX which holds 1.58 million shares worth $659.14M or 0.61% of the total VRTX shares outstanding followed by NATIONAL PENSION SERVICE with ownership of 454.54 thousand shares representing 0.18% of the VRTX ownership. CHEVY CHASE TRUST HOLDINGS, LLC is the third largest stakeholder with 443.83 thousand shares or 0.17% of the ownership worth more than $185.52M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VRTX is concerned, it is a stock which is optionable.

Number of VRTX shares short is 4.39M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 257.53M shares of VRTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VRTX has 256.75M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VRTX is 2.1.